No profile data available.
Vyome Holdings, Inc. (HIND) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Cambridge, United States, with about 17 full-time employees.
It reported revenue of $415,940 for fiscal year 2023, up 8.6% from fiscal year 2022, and net income of -$719,920. Its largest business segment, Product, brought in 55% of segment revenue in fiscal year 2025. Its market capitalization was $28.73 million as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2023; market data as of December 4, 2025.
, a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Cambridge, Massachusetts.
Vyome reported $415,940 in revenue for fiscal year 2023, up 8.6% from $382,865 in fiscal year 2022.
Product, with $174,645 or 55% of segment revenue in fiscal year 2025. Next: License (37%) and Royalty (9%).
$28.73 million as of December 4, 2025.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Growth Stalk Holdings Corp (GSTK), Impact BioMedical Inc. (IBO), Revium Rx (RVRC), BeyondSpring Inc. (BYSI).